Table 1.
Site | Gene | Drug | Accept with No Update | Accept with Update | Explicit Cancel | Implicit Cancel | View Educational Materials | Override with Reason | Override with No Reason | Other |
---|---|---|---|---|---|---|---|---|---|---|
Cincinnati Children’s | CYP2D6 | codeine | X | X | ||||||
oxycodone | ||||||||||
hydrocodone | ||||||||||
tramadol | ||||||||||
Marshfield Clinic | CYP2C19 | clopidogrel | X | X | X | |||||
SLCO1B1 | simvastatin | X | X | X | ||||||
CYP2C9, VKORC1 | warfarin | X | X | X | ||||||
Mayo Clinic | CYP2C19 | clopidogrel | X | X | X | |||||
SLCO1B1 | simvastatin | X | X | X | ||||||
CYP2C9, VKORC1 | warfarin | X | X | X | ||||||
Mt. Sinai | CYP2C19 | clopidogrel | X | X | X | X | X | X | X | |
SLCO1B1 | simvastatin | X | X | X | X | X | X | X | ||
CYP2C9, VKORC1 | warfarin | X | X | X | X | X | X | X | X | |
Northwestern | CYP2C19 | clopidogrel | X | X | X | X | ||||
SLCO1B1 | simvastatin | X | X | X | X | |||||
CYP2C9, VKORC1 | warfarin | X | X | X | X | |||||
Vanderbilt | CYP2C19 | clopidogrel | X | X | X | X | ||||
CYP2C9, VKORC1 | warfarin | X | X |
Sites varied in the actions that they provided to users on PGx CDS alerts, which affected the Accept, Override, and Ignore rates found upon aggregation. Table includes only the 6 sites that submitted data for aggregation in Table 2.